Search

Your search keyword '"Ebisawa M"' showing total 719 results

Search Constraints

Start Over You searched for: Author "Ebisawa M" Remove constraint Author: "Ebisawa M"
719 results on '"Ebisawa M"'

Search Results

1. Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study

2. A European‐Japanese study on peach allergy: IgE to Pru p 7 associates with severity

3. COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations

4. A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity

5. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN)

6. Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis

8. WAO consensus on definition of food allergy severity (DEFASE)

11. Updated threshold dose-distribution data for sesame

13. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions

14. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update – XIV – Recommendations on CMA immunotherapy

15. COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations

17. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

18. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

19. Enhanced transcriptional heterogeneity mediated by NF-κB super-enhancers

20. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

21. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

22. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

23. Management of anaphylaxis due to COVID-19 vaccines in the elderly

24. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper (vol 12, 100080, 2020)

25. Prevention and management of allergic reactions to food in child care centers and schools: Practice guidelines

26. Update on food allergy

27. Allergie au pollen de Cupressacées : sensibilisation à Cry j 7 chez des enfants japonais allergiques au pollen de cèdre du Japon et aux fruits

28. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

29. Acute asthma management during SARS-CoV2-pandemic 2020

30. Global implementation of the world health organization's International Classification of Diseases (ICD)-11: The allergic and hypersensitivity conditions model

31. Biological treatments in allergy: Prescribing patterns and management of hypersensitivity reactions

32. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

33. A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020

34. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

41. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases

42. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

43. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

44. 2019 ARIA Care pathways for allergen immunotherapy

46. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2)

47. Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases–11

48. 2019 ARIA Care pathways for allergen immunotherapy [ARIA-Versorgungspfade für die Allergenimmuntherapie 2019]

49. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

50. 2019 ARIA Care pathways for allergen immunotherapy

Catalog

Books, media, physical & digital resources